BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in BioCardia, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −7 vs. Q2 2023
- Shares held
- 1.65M
- −6.00K (−0.4%) vs. Q2 2023
- Total value
- $709.6K
- −$3.72M (−84.0%) vs. Q2 2023
- New holders
- 1
- 1 more added
- Sold out
- 8
- 5 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.65M |
| Q1 2026 | 18 | $831.1K |
| Q4 2025 | 20 | $812.3K |
| Q3 2025 | 18 | $551.9K |
| Q2 2025 | 16 | $593.2K |
| Q1 2025 | 12 | $623.8K |
| Q4 2024 | 13 | $272.2K |
| Q3 2024 | 9 | $316.6K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 22 | $790.8K |
| Q4 2023 | 24 | $1.37M |
| Q3 2023 | 16 | $709.6K |
| Q2 2023 | 23 | $4.43M |
| Q1 2023 | 23 | $4.09M |
| Q4 2022 | 25 | $4.87M |
| Q3 2022 | 23 | $3.17M |
| Q2 2022 | 26 | $3.10M |
| Q1 2022 | 24 | $5.49M |
| Q4 2021 | 23 | $5.78M |
| Q3 2021 | 22 | $9.01M |
| Q2 2021 | 20 | $12.3M |
| Q1 2021 | 19 | $13.5M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding BioCardia, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 650,763 | $279.8K | 0.00% | 00.0% | Unchanged |
| CM Management, LLC | 600,000 | $257.9K | 0.27% | +257,000+74.9% | Added |
| Geode Capital Management, LLC | 145,155 | $62.0K | 0.00% | 00.0% | Unchanged |
| Family Management Corp | 77,500 | $33.3K | 0.01% | 00.0% | Unchanged |
| Brown Advisory Inc | 33,085 | $14.2K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 31,718 | $13.6K | 0.00% | −1,295−3.9% | Reduced |
| Advisor Group Holdings, Inc. | 21,373 | $9.19K | 0.00% | −28,640−57.3% | Reduced |
| State Street Corp | 21,000 | $8.97K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 19,226 | $8.27K | 0.00% | 00.0% | Unchanged |
| Wedbush Securities Inc | 15,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 10,500 | $5.00K | 0.00% | −7,200−40.7% | Reduced |
| Commonwealth Equity Services, LLC | 10,092 | $4.00K | 0.00% | −47,886−82.6% | Reduced |
| HRT Financial LP | 10,502 | $4.00K | 0.00% | +10,502 | New |
| Bank of America Corp | 6,528 | $2.80K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 983 | $423 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 93 | $40 | 0.00% | −9−8.8% | Reduced |
| Lynwood Capital Management Inc. | 0 | $0 | 0.00% | −128,924−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −30,751−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −12,578−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −11,844−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,593−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −615−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −143−100.0% | Sold out |
| WealthPLAN Partners, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |